Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1997 Nov 25;94(24):13245–13250. doi: 10.1073/pnas.94.24.13245

Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors

Laurence G Rahme *,†, Man-Wah Tan *,‡, Long Le †,§, Sandy M Wong *, Ronald G Tompkins †,§, Stephen B Calderwood ¶,‖, Frederick M Ausubel *,†,**
PMCID: PMC24294  PMID: 9371831

Abstract

We used plants as an in vivo pathogenesis model for the identification of virulence factors of the human opportunistic pathogen Pseudomonas aeruginosa. Nine of nine TnphoA mutant derivatives of P. aeruginosa strain UCBPP-PA14 that were identified in a plant leaf assay for less pathogenic mutants also exhibited significantly reduced pathogenicity in a burned mouse pathogenicity model, suggesting that P. aeruginosa utilizes common strategies to infect both hosts. Seven of these nine mutants contain TnphoA insertions in previously unknown genes. These results demonstrate that an alternative nonvertebrate host of a human bacterial pathogen can be used in an in vivo high throughput screen to identify novel bacterial virulence factors involved in mammalian pathogenesis.

Keywords: gacA, pyocyanin, virulence model


Pseudomonas aeruginosa is a ubiquitous Gram-negative bacterium isolated from soil, water, and plants (1), and is an opportunistic human pathogen that infects patients who are immunodeficient or otherwise compromised. A variety of P. aeruginosa virulence factors have been described, and the majority of these, such as exotoxin A, elastase, and phospholipase C, were first detected biochemically on the basis of their cytotoxic activity (2). Subsequently, the genes corresponding to these factors or genes that regulate the expression of these factors were identified. In general, most pathogenicity-related genes in mammalian bacterial pathogens were first detected by using a biochemical assay. In contrast to mammalian pathogens, simple systematic genetic strategies have been routinely employed to identify pathogenicity-related genes in plant pathogens. Following random transposon-mediated mutagenesis, thousands of mutant clones of the phytopathogen are inoculated separately into individual plants to determine if they contain a mutation that affects the pathogenic interaction with the host (38). Comparable experiments with whole-animal mammalian pathogenicity models are not feasible because of the vast number of animals that must be subjected to pathogenic attack.

Reports indicating similarities between plant and animal pathogens (9, 10) prompted us to search for a strain of P. aeruginosa that was capable of eliciting disease in both a well-defined plant pathogenesis model and a well-defined animal pathogenesis model. Recently, we described (11) a clinical isolate of P. aeruginosa, UCBPP-PA14, that is infectious in both an Arabidopsis thaliana leaf infiltration model and in a mouse full-thickness skin thermal burn model. We showed that mutations in three P. aeruginosa pathogenicity-related genes, toxA, plcS, and gacA, caused significant decrease in pathogenicity in both models (11). The utilization of common virulence-related genes by P. aeruginosa for infecting animals and plants led us to hypothesize that previously unknown virulence determinants required for P. aeruginosa pathogenesis in animals could be identified by screening randomly mutagenized UCBPP-PA14 clones for ones that exhibited decreased virulence in plants. A subset of these mutants would be expected to correspond to genes that encode common virulence determinants for plant and animal pathogenesis. Such a systematic genetic approach should not only lead to a better understanding of the mechanisms of Pseudomonas infections, but should also lead to important information concerning the type of virulence strategies that are functionally conserved during evolution.

MATERIALS AND METHODS

Strains, Growth Conditions, and Plasmids.

P. aeruginosa strain UCBPP-PA14 is a human clinical isolate used in this study for the identification of novel virulence-related genes (11), and P. aeruginosa strains PAK (12) and PAO1 (13) have been studied extensively in many laboratories. Luria–Bertani (LB) broth and agar were used for the growth of P. aeruginosa and Escherichia coli strains at 37°C. Minimal medium (M9) was also used for the growth of P. aeruginosa.

Transposon Mutagenesis.

Transposon-mediated mutagenesis of UCBPP-PA14 was performed by using TnphoA carried on the suicide plasmid pRT731 in E. coli strain SM10 λpir (14). Donor and recipient cells were plated together on LB agar plates and incubated at 37°C for 8–10 h and subsequently plated on LB plates containing rifampicin (100 μg/ml) (to select against the E. coli donor cells) and kanamycin (200 μg/ml) (to select for TnphoA containing P. aeruginosa cells). Colonies that grew on the rifampicin and kanamycin media were replicated to LB containing ampicillin (300 μg/ml); ampicillin-resistant colonies indicated pRT731 integration into the UCBPP-PA14 genome and were discarded.

Alkaline Phosphatase Activity.

A total of 2,500 prototrophic UCBPP-PA14 TnphoA mutants were screened on peptone glucose agar plates (15) containing 40 μg/ml 5-bromo-4-chloro-3-indoly phosphate (XP). Peptone medium was selected because it suppresses the production of the endogenous blue-green pigment pyocyanin and the fluorescent yellow pyoverdin, permitting visualization of the blue color that results from dephosphorylation of XP by periplasmic alkaline phosphatase generated by PhoA+ mutants.

Growth Conditions and Mutant Isolation Strategy.

P. aeruginosa strains that were grown to saturation in LB broth at 37°C were washed in 10 mM MgSO4, resuspended at an optical density of 0.2 (OD600 = 0.2) in 10 mM MgSO4, and diluted 1:100 and 1:1,000 (corresponding to a bacterial density of ≈106 and 105 cfu/ml, respectively). Approximately 10 μl of the diluted cells were inoculated with a Pipetman into stems of an ≈12-week-old lettuce plants (variety Romaine or Great lake) grown in MetroMix potting soil in a greenhouse (26°C). The stems were washed with 0.1% bleach and placed on 15 cm diameter Petri dishes containing one Whatman filter (Whatman #1) that was impregnated with 10 mM MgSO4. The midrib of each lettuce leaf was inoculated with three different TnphoA-generated P. aeruginosa mutants to be tested and the wild-type UCBPP-PA14 strain as a control. The plates were kept in a growth chamber during the course of the experiment at 28–30°C and 90–100% relative humidity. Symptoms were monitored daily for 5 days.

In the Arabidopsis leaf infiltration model, P. aeruginosa strains grown and washed as above were diluted 1:100 in 10 mM MgSO4 (corresponding to a bacterial density of 103/cm2 leaf disk area) and were injected into leaves of 6-week-old Arabidopsis plants ecotype Llagostera as described for infiltration of Pseudomonas syringae (11, 16). Incubation conditions and monitoring of symptoms were the same as in the lettuce experiments. Leaf intercellular fluid containing bacteria was harvested and bacterial counts were determined as described (11, 16). Four different samples were taken by using two leaf discs per sample. Control plants inoculated with 10 mM MgSO4 showed no symptom development.

Mice Mortality Studies.

A 5% total surface area burn was fashioned on the outstreached abdominal skin of 6-week-old male AKR/J mice (The Jackson Laboratories) weighing between 25 and 30 g as described (11, 17). Immediately following the burn, mice were injected with 5 × 103 or 5 × 105 P. aeruginosa cells, and the number of animals that died of sepsis was monitored each day for 10 days. Animal study protocols were reviewed and approved by the subcommittee on Animal Studies of the Massachusetts General Hospital. Statistical significance for mortality data was determined by using a χ2 test with Yates’ correction or Fisher’s exact test. Differences between groups were considered statistically significant at P ≤ 0.05.

DNA Manipulation, Molecular Cloning, and Sequence Analysis of TnphoA Mutants.

P. aeruginosa chromosomal DNA was isolated by phenol extraction (18), and DNA blotting and hybridization studies were performed as described (19). The oligonucleotides 5′-AATATCGCCCTGAGCAGC-3′ (LGR1), and 5′-AATACACTCACTATGCGCTG-3′ (LGR2) correspond to sequences on opposite strands at the 5′ end of TnphoA. The oligonucleotides 5′-CCATCTCATCAGAGGGTA-3′ (LGR3) and 5′-CGTTACCATGTTAGGAGGTC-3′ (LGR4) correspond to sequences on opposite strands at the of the 3′ end of TnphoA. LGR1 + LGR2 or LGR3 + LGR4 were used to amplify by inverse PCR (IPCR) DNA sequences adjacent to the sites of TnphoA insertion as described (20). Amplified DNA fragments ranging in size from 350 to 650 bp were cloned into pBlueScript SK+/− by filling in the ends of the IPCR products prior to subcloning them into the EcoRV site of pBlueScript SK+/−. To determine the sequence of IPCR-amplified products, double-stranded DNA sequencing was performed with the Sequenase 2.0 kit (United States Biochemical). Sequences obtained were compared with the nonredundant peptide sequence databases at the National Center for Biotechnology Information by using the blastx program (21).

Isolation and Manipulation of a the Wild-Type Gene Corresponding to the pho34B12 Mutation.

The IPCR product that was generated from UCBPP-PA14 TnphoA mutant pho34B12 mutant was labeled with a random primed DNA labeling kit (Boehringer Mannheim) and used to probe a genomic library of UCBPP-PA14 chromosomal DNA in pJSR1 (11) for a clone containing the gene corresponding to the pho34B12 mutation. A 3.7-kb EcoRI fragment, identified in cosmid clone pLGR34B12 which corresponded to the pho34B12 mutation, was subcloned into the EcoRI site of pRR54 (22) after filling-in the ends of both vector and fragment to construct pLGRE34B12. The same fragment (made blunt ended) was subcloned into the SmaI site of pCVD (23) to construct pLGR34. pLGR34 was used to replace the mutated pho34B12 gene with a wild-type copy as described (23). The 3.7-kb EcoRI fragment was also subcloned into the EcoRI site of pBlueScript SK+/− to construct pBSR34B12 and used for DNA sequence analysis.

A 1,659-bp sequence corresponding to the pho34B12 insertion that contains two overlapping ORFs (ORF1 and ORF2) on opposing strands was submitted to GenBank and was assigned accession number AF031571. ORF1 is 1,148 bp (nucleotides 361–1,509) and ORF2 is 1,022 bp (nucleotides 1,458–436). The overlap of the two ORFs is from nucleotides 436–1,458. ORF1 contains a second putative translational start site at nucleotide 751 corresponding to a coding region of 758 bp. The oligonucleotide primers 5′-CGCATCGTCGAAACGCTGGCGGCC-3′ and 5′-GCCGATGGCGAGATCATGGCGATG-3′ were used to amplify a 1,100-bp fragment from pBSR34B12 containing ORF1. Because of the two putative initiation sites present in ORF1, the oligonucleotide primers 5′-TGCGCAACGATACGCCGTTGCCGACGATC-3′ and 5′-GATTCCACCTTCGCAGCGCAGCCC-3′ (Reg3) were also used to amplify a 1,659 bp from pBSR34B12 containing ORF1. The oligonucleotide primers 5′-GATTCCACCTTCGCAGCGCAGCCC-3′ and 5′-GCCGATGGCGAGATCATGGCGATG-3′ were used to amplify a 1,302-bp fragment from pBSR34B12 containing ORF2. All primer combinations were designed to contain the putative upstream regulatory elements of each ORF. The PCR products obtained (1,100, 1,659, and 1,302 bp) were cloned into pCR2.1 (Invitrogen) to construct pLE15, pLE1, and pLE2, respectively. All three PCR products were subcloned into pRR54 to construct pRRLE15, pRRLE1, and pRRLE2, respectively.

Enzymatic Activities of TnphoA Mutants.

P. aeruginosa strains grown for 18 h in LB were used for assays of enzymatic activities. Proteolytic and elastolytic activities were determined as described (24). Quantitation of pyocyanin was determined as described (25). Hemolytic activity was detected following incubation on plates containing Trypticase soy agar (BBL) supplemented with 5% sheep red blood cells (26).

Generation of a Nonpolar gacA Mutation.

A nonpolar gacA mutation in UCBPP-PA14 was constructed by cloning a 3.5-kb PstI fragment containing the gacA gene from cosmid pLGR43 (11) into the unique BamHI restriction site in the suicide vector pEGBR (27) by using BamHI linkers. A 950-bp EcoRI–HincII Klenow end-filled fragment containing the kanamycin resistance gene cassette from pUC18K (28) was then cloned into the unique BamHI restriction site (made blunt ended) in gacA, such that transcription is maintained and translation of the downstream portion of gacA is reinitiated at the 3′ end of the kanamycin cassette. The resultant construct, SW 7-4, containing the kanamycin gene cassette within the gacA gene and in the orientation of its transcription, was used to marker-exchange by homologous recombination the disrupted gacA gene into the wild-type UCBPP-PA14 genome.

RESULTS

By using the procedures described in Materials and Methods, we mutagenized the P. aeruginosa UCBPP-PA14 genome with the transposon TnphoA and screened 2,500 prototrophic mutants for impaired pathogenicity in a lettuce stem assay. In our previous publication on UCBPP-PA14, the plant leaf infiltration model for UCBPP-PA14 utilized Arabidopsis (11), but we substituted lettuce in these current studies because several mutants could be tested on a single lettuce stem. Interestingly, we found that lettuce was not only susceptible to infection by UCBPP-PA14 but also was susceptible to the well-characterized P. aeruginosa strains PAK (12) and PAO1 (13). Both of these latter strains proliferated in lettuce leaves and elicited disease symptoms similar to those elecited by UCBPP-PA14, characterized by water soaking followed by soft rot 4–5 days postinfection (data not shown). In later stages of infection, all three P. aeruginosa strains invaded the entire midrib of a lettuce leaf resulting in complete maceration and collapse of the tissue.

As summarized in Table 1, we identified nine TnphoA-generated mutants of UCBPP-PA14 among the 2,500 prototrophs screened that elicited null, weak, or moderate rotting symptoms on lettuce stems compared with the wild-type strain. Severe maceration of the leaf was not observed with any of the mutants. DNA blot analysis showed that each of the nine mutants contains a single TnphoA insertion, using as a probe a 1,542-bp BglI–BamHI fragment containing the kanamycin resistance conferring gene of TnphoA (14). Two of the nine UCBPP-PA14 TnphoA mutants, pho34B12 and pho15, expressed alkaline phosphatase activity suggesting that the genes containing these TnphoA insertions encode membrane-spanning or secreted proteins (14, 29).

Table 1.

P. aeruginosa mutants obtained by TnphoA mutagenesis

Strain Growth in Arabidopsis leaves* Symptoms elicited in Arabidopsis % mouse mortality
Gene identity
5 × 103 5 × 105
PA14 5.5  ×  107 Severe 53 100
33C7 8.3  ×  104 None 0 0 Unknown§
1D7 7.5  ×  105 Weak 0 50 gacA
25A12 1.7  ×  106 Weak 11 87 Unknown
33A9 5.1  ×  106 Moderate 0 0 Unknown
25F1 1.5  ×  104 Moderate 0 20 Unknown
34H4 3.8  ×  106 Moderate 0 33 Unknown
pho34B12 4.0  ×  106 Moderate 0 56 Unknown
pho15 3.9  ×  104 Moderate 0 62 dsbA
16G12 2.3  ×  105 Moderate 20 100 Unknown
*

Four different samples were taken using two leaf discs/sample. Control plants inoculated with 10 mM MgSO4 showed no symptoms during the course of the experiments. Three independent experiments gave similar results. 

Symptoms observed 4–5 days after infection. None, no symptoms; chlorosis, chlorosis circumscribing the inoculation site; weak, localized water-soaking and chlorosis of tissue circumscribing the inoculation site; moderate, moderate water-soaking and chlorosis with most of the tissue softened around the inoculation site; severe, severe soft-rotting of the entire leaf characterized by a water-soaked reaction zone and chlorosis around the inoculation site at 2–3 days postinfection. 

All animal experiments were conducted at least twice using 8–10 animals/experiment. Independent experiments showed similar percentage mortality rates. Mice were injected with ≈ 5 × 103 or 5 × 105 cells. 

§

blastx analysis yielded no encoded proteins with significant homology. 

The nine TnphoA mutants were further tested by measuring their growth rate over the course of 4 days in Arabidopsis leaves as a quantitative measure of pathogenicity (11, 16). Although none of the mutants showed any significant differences in their growth rates as compared with the wild-type strain in either rich or minimal medium, the growth rate over time of all nine mutants in Arabidopsis leaves was significantly lower than the wild type strain. Table 1 lists the maximal levels of growth reached by each mutant at the fourth day postinfection. In the case of all nine mutants, less severe symptom development reflected reduced bacterial counts in leaves. All of the mutants except 33C7 elicited either weak or moderate rot and water soaking symptoms with varying amounts of chlorosis (yellowing) (Table 1). Interestingly, however, as summarized in Table 1, the levels of proliferation of the individual mutants did not directly correlate with the severity of symptoms that they elicited. For example, even though mutant 25A12 grew to similar levels as mutants 33A9, pho34B12, and 34H4, only 10-fold less than wild-type UCBPP-PA14, mutant 25A12 elicited very weak symptoms. Similarly, mutants 33C7, pho15, and 25F1 all reached similar maximal levels of growth (≈103-fold less than the growth of the wild type); however, only mutant 33C7 failed to cause any disease symptoms (Table 1). The differences observed in the degree of symptoms and proliferation levels among the nine mutants suggest that these mutants may carry insertions in genes that are involved in various stages of the plant infectious process.

The pathogenicity of each of the nine TnphoA-generated mutants that were less pathogenic in the plant leaf assay was measured in a full-thickness skin thermal burn mouse model (11, 17). As shown in Table 1, all nine mutants were significantly different from the wild-type with a P ≤ 0.05 at both doses except for 25A12 and16G12, which were not significantly different from wild type at the higher dose of 5 × 105 cells. In addition, mutant 33A9 also failed to cause mortality even at a higher dose of 5 × 106.

We used DNA blot analysis and DNA sequence analysis to determine whether TnphoA in the nine less pathogenic mutants had inserted into known genes. DNA blot analysis revealed that mutant 1D7 contains a TnphoA insertion in the gacA gene (30, 31), which we had shown previously to be an important pathogenicity factor for P. aeruginosa in both plants and animals (11). For the other eight mutants we used the IPCR to generate amplified products corresponding to DNA sequences adjacent to the sites of the TnphoA insertions (20). The IPCR products were cloned and then subjected to DNA sequence analysis. Mutant pho15 contains TnphoA inserted into a P. aeruginosa gene (from strain PA01) previously deposited in GenBank (accession no. U84726) that shows a high degree similarity to the Azotobacter vinelandii dsbA gene, which encodes a periplasmic disulfide bond forming enzyme (32). Homologues of dsbA in the bacterial phytopathogen Erwinia chrysanthemi and in the human pathogens Shigella flexneri and Vibrio cholera are required for pathogenesis (3335). Computer analysis with the program blastx showed that when the DNA sequences corresponding to the remaining seven TnphoA insertions were translated in all possible reading frames, no significant similarities to any known genes were found (Table 1).

We performed a variety of biochemical tests to categorize the nine less pathogenic UCBPP-PA14 mutants on the basis of whether they exhibited defects in previously described primary virulence factors and/or metabolic pathways. All mutants were assayed for protease, elastase and phospholipase activities and for their ability to secrete the secondary metabolite pyocyanin (2426). Pyocyanin is a redox-active phenazine compound excreted by most clinical strains of P. aeruginosa that kills mammalian and bacterial cells through the generation of reactive oxygen intermediates and which has been implicated as a P. aeruginosa virulence factor (3638). Mutants 33C7, 33A9, 34H4, 25F1, and 16G12 showed no defects in any of the biochemical assays used. Mutant pho34B12 showed decreased hemolytic activity on blood agar plates, reduced elastase activity (≈50%), and no detectable pyocyanin production. Mutant pho15 showed only traces of elastase activity and a decrease in proteolytic activity (60–70%) compared with the wild type. Mutant 25A12 showed a 50% decreased elastolytic activity. Finally, mutant 1D7, which contains an insertion in gacA, showed reduced levels of pyocyanin (≈50%) as compared with the wild type. In addition to mutant 1D7 a second independent gacA::TnphoA mutant was identified from the plant screen, mutant 33D11. This latter mutant also exhibited a similar reduction in pyocyanin production and reduced virulence in both plants and mice.

On the basis of the DNA sequence analysis and biochemical testing of the mutants, the genes targeted by the TnphoA insertions in mutants 1D7 and pho34B12 were chosen for further analysis. As discussed above, 1D7 contains an insertion in gacA that we had shown previously to encode a virulence factor in P. aeruginosa (11). Recently a gacA-like gene has also been shown to be an important virulence factor for Salmonella typhimurium (39). However, the two gacA::TnphoA insertions (1D7 and 33D11) isolated in this study, the gacA insertion mutant that we constructed previously (11) and an independently constructed P. aeruginosa gacA mutation that affects the production of several known virulence factors (36), all exert a polar effect on at least one gene, a homologue of the E. coli uvrC gene immediately downstream of gacA (11, 30, 40). To provide definitive evidence that the loss of pathogenicity phenotypes of the gacA mutants constructed in our laboratory was caused by the disruption of the gacA ORF per se rather than caused by a polar effect on a gene downstream of gacA, we constructed, as described in Materials and Methods, a nonpolar gacA mutation in UCBPP-PA14 with a DNA cassette encoding a gene that confers kanamycin resistance. Importantly, the nonpolar gacA mutant exhibited the same diminished level of pathogenicity in the mouse assay (50% mortality) and in the Arabidopsis assay (growth to 3 × 105 cfu/cm2 after 4 days) as the gacA::TnphoA mutant (1D7), but did not exhibit the UV sensitivity of the polar gacA mutants. Like 1D7, the nonpolar gacA mutant also excreted lower levels of pyocyanin (50%) compared with the wild type.

Mutant pho34B12 was chosen for further analysis for the following reasons. First, the insertion in pho34B12 is situated directly downstream of the P. aeruginosa pyocyanin biosynthetic genes phnA and phnB (25) in a previously uncharacterized region of the P. aeruginosa genome. Second, the pho34B12 insertion causes a pleiotropic phenotype that includes reduced elastase and hemolytic activities, suggesting that the gene in which the pho34B12 TnphoA insertion is situated may encode a regulator of diverse pathogenicity factors.

To rule out the possibility that a secondary mutation in pho34B12 was responsible for the loss of pathogenicity phenotype rather than the TnphoA insertion, we replaced the pho34B12::TnphoA mutation by homologous recombination with the corresponding wild-type gene. This replacement resulted in restoration of the pathogenicity defect in both plants and animals as well as restoration of hemolytic and elastolytic activity and pyocyanin production to wild-type levels (Table 2). These results show that the TnphoA insertion in pho34B12 is the cause of the pleiotropic phenotype of this strain, including the loss of pathogenicity phenotype. The fact that no putative ORFs are in the next 500 bp downstream of the stop codon following the pho34B12::TnphoA insertion (see below) makes it unlikely that TnphoA exerts a polar effect on a downstream gene that is responsible for the phenotype of mutant pho34B12. Genetic complementation analysis of pho34B12 with a plasmid (pLGRE34B12) containing a 3.7-kb insert that includes pho34B12 and part of the phnAB region resulted in restoration of the elastase and hemolytic activities to wild-type levels and more than 10-fold overproduction of pyocyanin (Table 2). However, the impaired pathogenicity phenotype of pho34B12 in both Arabidopsis and mice was not complemented by pLGRE34B12 (Table 2), most likely because of the presence of multiple copies of the wild-type gene corresponding to pho34B12.

Table 2.

Complementation analysis of pho34B12

Strain Growth in Arabidopsis leaves Symptoms elicited in Arabidopsis % mouse mortality, 5 × 105 % pyocyanin
PA14 5.5  ×  107 Severe 100 100
pho34B12 4.0  ×  106 Moderate 56 ≤1
pho34B12 3.9  ×  107 Severe 100 120
Reconstructed to
 wild type
pho34B12 6.1  ×  105 Moderate 0 600
+pLGRE34B12
pho34B12 7.0  ×  105 Moderate 13 40
 +pRRLE2
pho34B12 5.0  ×  105 Moderate 13 1,400
 +pRRLE1
pho34B12 1.0  ×  105 Moderate 22 1,360
 +pRRLE15

Further DNA sequence analysis showed that the region containing the pho34B12 mutation encodes two almost completely overlapping ORFs (ORF1 and ORF2) that are transcribed in opposite directions. Moreover, ORF1 has two potential methionine start codons (designated OFR1-S and ORF1-L). The predicted proteins encoded by ORF1-S and ORF1-L, which are transcribed in the same direction as the phnA, phnB, and phoA genes, contain a consensus motif that corresponds to a lipid attachment site found in a variety of prokaryotic membrane lipoproteins (41). These membrane lipoproteins are synthesized with a precursor signal peptide, providing an explanation for the Pho+ phenotype of the pho34B12 insertion (41). The predicted protein encoded by ORF2 contains an N-terminal helix-turn-helix DNA-binding motif similar to the helix-turn-helix motif found in the LysR family of transcriptional regulators (42, 43). This class of proteins includes regulators involved in both mammalian and plant pathogenesis (44). The existence of two functional almost completely overlapping ORFs is unusual in bacterial genomes.

To determine which of the ORFs encoded in the pho34B12 region are functional, additional complementation analysis was carried out by using plasmids that contained PCR products corresponding to ORF1-S, ORF1-L, and ORF2. The production of both pyocyanin and elastolytic activity was restored to 20–40% of wild-type levels by the plasmid synthesizing the protein encoded by ORF2 (pRRLE2). Similarly, the hemolytic ability of this complemented strain was partially restored. Complementation of pho34B12 with plasmids pRRLE1 and PRRLE15, corresponding to ORF1-S and ORF1-L, respectively, also restored the hemolytic, pyocyanin, and elastolytic activities. Interestingly, however, the presence of plasmids pRRLE1 and PRRLE15 resulted in a 10-fold higher production of pyocyanin and a 2-fold higher level of elastase activity. Neither pRRLE1, pRRLE15 or pRRLE2 complemented the loss of pathogenicity phenotypes of mutant pho34B12 in either plants or animals (Table 2). Further characterization of this region including site-directed mutagenesis is necessary to determine which of the three ORFs is (are) required for pathogenicity in plants and animals.

DISCUSSION

The data presented in this paper clearly demonstrate that previously unknown P. aeruginosa virulence factors (genes) that play a significant role in mammalian pathogenesis can be readily identified by screening random P. aeruginosa mutants for ones that display attenuated pathogenic symptoms in plants. This result is consistent with our previous study in which we demonstrated that at least three P. aeruginosa genes encode virulence factors involved in both plant and animal pathogenesis (11). On the other hand, we did not expect to find that all nine of the mutants that were isolated because of decreased virulence in plants would also be less virulent in mice. The simplest interpretation of this result is that P. aeruginosa pathogenesis in plants and animals is the result of a substantially overlapping set of genes that may be considered to be basic virulence genes. Another possible interpretation is that some of the identified genes may encode regulatory proteins (i.e., pho34B12), that control different effector molecules, a subset of which may be specific for either plants or animals. We also did not expect that the majority of mutants that would be identified in this study (seven of nine) would corresponded to previously unknown genes. By using the Poisson distribution, a genome size for P. aeruginosa of 5.9 Mb and an average gene size of 1.1 kb, we calculated that the 2,500 mutants tested represents 25% of the total number that needs to be tested to give ≈95% probability of testing each gene in the assay. Therefore, because our screen for P. aeruginosa virulence mutants is not nearly saturated, it is likely that many additional P. aeruginosa genes with important roles in pathogenicity await discovery.

Importantly, at least two of the previously known virulence-related factors (genes) identified in our model as being important in plant pathogenesis are not only important virulence factors for P. aeruginosa in a mouse burn model, but have also been described as important virulence factors in other Gram-negative pathogens. These latter pathogenicity factors (genes) include dsbA, and gacA (3335, 39). This finding makes it likely that many of the previously unknown factors identified in P. aeruginosa will be generally relevant for Gram-negative pathogenesis.

Another important conclusion from this study is that the high throughput in vivo screening method that we have developed can lead to the identification of pathogenicity factors that do not correlate with obvious biochemical defects. Mutants 33C7, 33A9, 34H4, 25F1, and 16G12 exhibited no detectable defects in several known P. aeruginosa pathogenicity factors and, two of these mutants 33C7 and 33A9 were among the most debilitated in the mouse model. Moreover, even though mutants pho34B12 and 25A12 did exhibit diminished production of known virulence factors, the genes corresponding to these mutants have not been identified previously, most likely because the biochemical defects in these mutants cannot be readily identified in a simple high throughput screen. This finding attests to the sensitivity of our screen for loss of pathogenicity phenotypes.

In the last few years, other high throughput screens for identifying bacterial pathogenicity factors have been described. The IVET (in vivo expression technology) identifies promoters that are specifically activated during pathogenesis (45, 46), STM (signature-tagged transposon method) identifies genes that are required for survival in a host (47), and DFI (differential fluorescence induction) utilizes green fluorescent protein and fluorescence-activated cell sorting to identify genes that are activated under specific conditions or in specific host cell types (48). These approaches are complimentary with the one that we have described in this paper; each approach has advantages and disadvantages. One advantage of our screening procedure in a nonvertebrate host is that it directly measures pathogenicity whereas the IVET and DFI methods measure pathogenicity-associated gene expression. One disadvantage of the STM procedure is that it only identifies genes whose function cannot be complemented in trans by the mixed population of bacterial mutants used for the inoculum, whereas our screen in a nonvertebrate involves testing each mutant clone separately.

Our laboratory is currently expanding the P. aeruginosa multi-host system to include additional nonvertebrate hosts including the nematode Caenorhabditis elegans (M.-W.T., S. Mahajan, and F.M.A., unpublished data) and insects, Drosophila melanogaster (S. Mahajan and F.M.A., unpublished data) and Galleria mellonella (G. Jander and F.M.A., unpublished data). P. aeruginosa is an affective pathogen of each of these organisms. It also seems likely that the multi-host pathogenesis model can be extended to other pathogens as well (49).

Acknowledgments

We thank Melissa Cunningham for the technical assistance. This work was supported in part by a grant from Shriner’s Hospitals for Children and by a grant from Hoechst AG to the Massachusetts General Hospital.

ABBREVIATIONS

LB

Luria–Bertani

IPCR

inverse PCR

Footnotes

Data deposition: The sequence reported in this paper has been deposited in the GenBank database (accession no. AF031571).

References

  • 1.Palleroni J N. In: Bergey’s Manual of Systematic Bacteriology. Bergey J G, Holt, editors. Baltimore, MD: Williams & Wilkins; 1984. pp. 141–172. [Google Scholar]
  • 2.Fink R B., Jr . Pseudomonas aeruginosa the Opportunist: Pathogenesis and Disease. Boca Raton, FL: CRC; 1993. [Google Scholar]
  • 3.Boucher C, Barberis P, Trigalet A, Demery D. J Gen Microbiol. 1985;131:2449–2457. [Google Scholar]
  • 4.Boucher C A, Van Gijsegem F, Barberis P A, Arlat M, Zischek C. J Bacteriol. 1987;169:5626–5632. doi: 10.1128/jb.169.12.5626-5632.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Comai L, Kosuge T. J Bacteriol. 1982;149:40–46. doi: 10.1128/jb.149.1.40-46.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lindgren P B, Peet R C, Panopoulos N J. J Bacteriol. 1986;168:512–522. doi: 10.1128/jb.168.2.512-522.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Rahme L G, Mindrinos M N, Panopoulos N J. J Bacteriol. 1991;173:575–586. doi: 10.1128/jb.173.2.575-586.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Willis D K, Hrabak E M, Rich J J, Barta T M, Lindow S E, Panopoulos N J. Mol Plant-Microbe Interact. 1990;3:149–156. [Google Scholar]
  • 9.Cho J J, Schroth M N, Kominos S D, Green S K. Phytopathology. 1975;65:425–431. [Google Scholar]
  • 10.Elrod R P, Braun A C. J Bacteriol. 1942;44:633–645. doi: 10.1128/jb.44.6.633-645.1942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Rahme L G, Stevens E J, Wolfort S F, Shao J, Tompkins R G, Ausubel F M. Science. 1995;268:1899–1902. doi: 10.1126/science.7604262. [DOI] [PubMed] [Google Scholar]
  • 12.Ishimoto K S, Lory S. Proc Natl Acad Sci USA. 1989;86:1954–1957. doi: 10.1073/pnas.86.6.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Holloway B W, Krishnapillai V, Morgan A F. Microbiol Rev. 1979;43:73–102. doi: 10.1128/mr.43.1.73-102.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Taylor R K, Manoil C, Mekalanos J J. J Bacteriol. 1989;171:1870–1878. doi: 10.1128/jb.171.4.1870-1878.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ostroff R M, Vasil A I, Vasil M L. J Bacteriol. 1990;172:5915–5923. doi: 10.1128/jb.172.10.5915-5923.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dong X, Mindrinos M, Davis K R, Ausubel F M. Plant Cell. 1991;3:61–72. doi: 10.1105/tpc.3.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stevens E J, Ryan C M, Friedberg J S, Barnhill R L, Yarmush M L, Tompkins R G. J Burn Care Rehabil. 1994;15:232–235. doi: 10.1097/00004630-199405000-00005. [DOI] [PubMed] [Google Scholar]
  • 18.Strom M S, Lory S. J Bacteriol. 1986;165:367–372. doi: 10.1128/jb.165.2.367-372.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ausubel F M, Brent R, Kingston R E, Moore D D, Seidman J G, Smith J A, Struhl K. Current Protocols in Molecular Biology. New York: Wiley; 1996. [Google Scholar]
  • 20.Ochman H, Medhora M M, Garza D, Hartl D L. In: PCR Protocols: A Guide to Methods and Applications. Innis M A, Gelfand D H, Sninsky J J, White T J, editors. San Diego: Academic; 1990. pp. 219–227. [Google Scholar]
  • 21.Gish W, States D J. Nat Genet. 1993;3:266–272. doi: 10.1038/ng0393-266. [DOI] [PubMed] [Google Scholar]
  • 22.Roberts R C, Burioni R, Helinski D R. J Bacteriol. 1990;172:6204–6216. doi: 10.1128/jb.172.11.6204-6216.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Donnenberg M S, Kaper J B. Infect Immun. 1991;59:4310–4317. doi: 10.1128/iai.59.12.4310-4317.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Toder D S, Gambello M J, Iglewski B H. Mol Microbiol. 1991;5:2003–2010. doi: 10.1111/j.1365-2958.1991.tb00822.x. [DOI] [PubMed] [Google Scholar]
  • 25.Essar D W, Eberly L, Hadero A, Crawford I P. J Bacteriol. 1990;172:884–900. doi: 10.1128/jb.172.2.884-900.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ostroff R M, Vasil M L. J Bacteriol. 1987;169:4597–4601. doi: 10.1128/jb.169.10.4597-4601.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Akerley B J, Cotter P A, Miller J F. Cell. 1995;80:611–620. doi: 10.1016/0092-8674(95)90515-4. [DOI] [PubMed] [Google Scholar]
  • 28.Menard R, Sansonetti P J, Parsot C. J Bacteriol. 1993;175:5899–5906. doi: 10.1128/jb.175.18.5899-5906.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Manoil C, Beckwith J. Proc Natl Acad Sci USA. 1985;82:8129–8133. doi: 10.1073/pnas.82.23.8129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Laville J, Voisard C, Keel C, Maurhofer M, Défago G, Haas D. Proc Natl Acad Sci USA. 1992;89:1562–1566. doi: 10.1073/pnas.89.5.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gaffney T D, Lam S T, Ligon J, Gates K, Frazelle A, DiMaio J, Hill S, Goodwin S, Torkewitz N, Allshouse A M, Kempf H-J, Becker J O. Mol Plant-Microbe Interact. 1994;7:455–463. doi: 10.1094/mpmi-7-0455. [DOI] [PubMed] [Google Scholar]
  • 32.Bardwell J C A, McGovern K, Beckwith J. Cell. 1991;67:581–589. doi: 10.1016/0092-8674(91)90532-4. [DOI] [PubMed] [Google Scholar]
  • 33.Shevchik V E, Bortoli-German I, Robert-Baudouy J, Robinet S, Barras F, Condemine G. Mol Microbiol. 1995;16:745–753. doi: 10.1111/j.1365-2958.1995.tb02435.x. [DOI] [PubMed] [Google Scholar]
  • 34.Peek J A, Taylor R K. Proc Natl Acad Sci USA. 1992;89:6210–6214. doi: 10.1073/pnas.89.13.6210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Watarai M, Tobe T, Yoshikawa M, Sasakawa C. Proc Natl Acad Sci USA. 1995;92:4927–4931. doi: 10.1073/pnas.92.11.4927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hassett D J, Charniga L, Bean K, Ohman D E, Cohen M S. Infect Immun. 1992;60:328–336. doi: 10.1128/iai.60.2.328-336.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kanthakumar K, Taylor G, Tsang K W, Cundell D R, Rutman A, Smith S, Jeffery P K, Cole P J, Wilson R. Infect Immun. 1993;61:2848–2853. doi: 10.1128/iai.61.7.2848-2853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Miller R A, Rasmussen G T, Cox C D, Britigan B E. Infect Immun. 1996;64:182–188. doi: 10.1128/iai.64.1.182-188.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Johnston C, Pegues D A, Hueck C J, Lee C A, Miller S I. Mol Microbiol. 1996;22:715–727. doi: 10.1046/j.1365-2958.1996.d01-1719.x. [DOI] [PubMed] [Google Scholar]
  • 40.Reimmann C, Beyeler M, Latifi A, Winteler H, Foglino M, Lazdunski A, Haas D. Mol Microbiol. 1997;24:309–319. doi: 10.1046/j.1365-2958.1997.3291701.x. [DOI] [PubMed] [Google Scholar]
  • 41.Hayashi S, Wu H C. J Bioenerg Biomembr. 1990;22:451–471. doi: 10.1007/BF00763177. [DOI] [PubMed] [Google Scholar]
  • 42.Henikoff S, Haughn G W, Calvo J M, Wallace J C. Proc Natl Acad Sci USA. 1988;85:6602–6606. doi: 10.1073/pnas.85.18.6602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Viale A M, Kobayashi H, Akazawa T, Henikoff S. J Bacteriol. 1991;173:5224–5229. doi: 10.1128/jb.173.16.5224-5229.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Finlay B B, Falkow S. Microbiol Mol Biol Rev. 1997;61:136–169. doi: 10.1128/mmbr.61.2.136-169.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wang J, Mushegian A, Lory S, Jin S. Proc Natl Acad Sci USA. 1996;93:10434–10439. doi: 10.1073/pnas.93.19.10434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mahan M J, Slauch J M, Mekalanos J J. Science. 1993;259:686–688. doi: 10.1126/science.8430319. [DOI] [PubMed] [Google Scholar]
  • 47.Hensel M, Shea J E, Gleeson C, Jones M D, Dalton E, Holden D W. Science. 1995;269:400–403. doi: 10.1126/science.7618105. [DOI] [PubMed] [Google Scholar]
  • 48.Valdivia R H, Falkow S. Mol Microbiol. 1996;22:367–378. doi: 10.1046/j.1365-2958.1996.00120.x. [DOI] [PubMed] [Google Scholar]
  • 49.Chadwick J S. Fed Proc. 1967;26:1675–1679. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES